Friday, October 2, 2020

Dr Reddy#39;s seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V

Dr Reddy#39;s seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V The Indian pharma giant has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution.

from Moneycontrol Business News https://ift.tt/3n9mTRz

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...